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Chemotherapy is a common cancer treatment, yet it has many severe side effects 
including altered taste. Patients report that salt taste is most affected by chemotherapy. The salt 
taste transduction system has yet to be fully elucidated. Type I taste cells are thought to be 
responsible in part for salt taste. The goal of this study was to determine how cyclophosphamide 
(CYP), a common chemotherapeutic agent, affects salt taste in mice. This involved two 
experiments. The first experiment examined how an induced conditioned taste aversion (CTA) to 
NaCl (salt) would change following CYP treatment. The second used a brief access test to 
observe how NaCl preference changed before and after either a single dose or multiple dose CYP 
treatment. We hypothesized that CYP would affect Type I taste cells leading to changes in salt 
preference, that CYP would reduce salt aversion, and that multiple doses would affect multiple 
salt taste cell types leading to more significant changes in salt preference. Our results 
demonstrated that after treatment, CYP mice had higher NaCl lick rates than control mice. This 
occurred in two phases, initially around day 8 and again around day 18. CTA mice maintained an 
aversion to NaCl following treatment, indicating a pathway protected from CYP disturbance. A 
single CYP injection and multiple CYP injections had the same effects on mice, indicating that 
this methodology is not useful in disturbing multiple salt taste cell populations. These data 
support that there are at least two salt taste transduction pathways in mice. 
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Chapter I: General Overview 
Introduction 
Chemotherapy is one of the most widely used cancer treatments. However, it can have 
many severe side effects that impact patients’ quality of life. One significant chemotherapy-
related side effect is altered taste. In a study of 518 patients undergoing chemotherapy, taste 
changes were self-reported by 67% of the patients, with 56% of patients experiencing oral 
problems and 22% experiencing appetite loss. Of the 67% of patients who reported taste 
changes, 41% reported that salt taste was affected, while sweet, bitter, and sour were less 
affected (36%, 24%, and 21% respectively) (Bernhardson, Tishelman, & Rutqvist, 2008). Salt, 
specifically NaCl, is one of the most widely used flavoring agents in many cultures. The addition 
of salt is not only used as a flavor enhancer itself, but can also be used to modify other tastes, 
such as masking bitter flavor and enhancing the perceived sweetness of a meal (Breslin & 
Beauchamp, 1997). Salt also increases the intensity of umami taste and of weak citric acid but 
decreases the intensity of lactic acid and strong citric acid (Kawasaki, Sekizaki, Hirota, Sekine-
Hayakawa, & Nonaka, 2016). Some degree of the weight loss that affects 22% of chemotherapy 
patients is likely attributable to appetite loss, which can further be attributed to taste changes 
(Kiss, Isenring, Gough, & Krishnasamy, 2014). Additionally, quality of life is greatly reduced if 
patients no longer enjoy eating since it serves not only a nutritional but also a social role in daily 
life (Bromley, 2000). Taste changes are the second most bothersome effect of chemotherapy 
reported in patients, with hair loss being first (Lindley et al., 1999). The first step in mitigating 
these taste changes is to further understand the mechanism in which chemotherapy affects salt 
taste receptor cells, which was the goal of the present study.  
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Background on taste 
The mammalian taste system is a complex set of receptors and pathways that has yet to 
be fully understood. Most mammals are able to sense five basic tastes: salty, sweet, bitter, sour, 
and umami. Between 2000 and 5000 onion-shaped epithelial chemosensory organs known as 
taste buds are located in the human oral cavity. These taste buds are distributed on the tongue, 
palate, epiglottis, pharynx, and larynx. The taste buds on the tongue are located in three distinct 
regions which are characterized by three different papillae, including fungiform, circumvallate, 
and foliate. Fungiform papillae are located on the anterior of the tongue, circumvallate papilla 
are located on the posterior of the tongue, and foliate are on the lateral sides of the tongue. 
Fungiform papillae are innervated by the chorda tympani nerve and circumvallate papillae are 
innervated by the glossopharyngeal nerve. Foliate papillae are innervated by branches from both 
the glossopharyngeal and the chorda tympani nerves. Taste buds located in the palate are 
innervated by the greater superficial petrosal nerve, which is a branch of the facial nerve (Roper, 
2013). 
 The three types of taste sensory cells are Type I, Type II, and Type III cells. 
(Yarmolinsky, Zuker, & Ryba, 2009). A fourth type of taste cell, Type IV cells, are 
undifferentiated cells which will mature to become either Type I, II, or III cells. Type I cells are 
defined by their electron-dense cytoplasm and elongate, pleomorphic nuclei and have glial-like 
function. These cells are characterized by lamellar processes that wrap the other taste cells. They 
also act as insulators by producing ecto-ATPase, which degrades the chemical signals of the 
other taste cells. Type II cells are defined by their expression of G protein-coupled receptors. 
While these cells do not possess typical synapses, it is now known that they secrete ATP which 
acts as a neurotransmitter to sensory afferent fibers. Type III cells, also known as presynaptic 
  Michael Gomella 
4 
 
cells, possess synapses and act as an intermediate between Type I and Type II cells. These cells 
secrete serotonin, norepinephrine, and GABA (Roper, 2013). Taste cells all have different 
lifespans, with Type II cells having a half-life of eight days and Type III cells having a half-life 
of 22 days. Type I cells, the cells of greatest interest in the present study, show two separate 
populations which have very different longevities. Three-fourths of the Type I cells have a half-
life of eight days, while the remainder of the Type I cells live for 24 days. It is predicted that the 
cells with a 24-day lifespan are likely immature, undifferentiated taste cells, while the cells with 
an eight-day lifespan are mature Type I cells (Perea-Martinez, Nagai, & Chaudhari, 2013). 
 Each cell type has a specific detection and transduction stimuli, some of which are not 
understood. Type II cells detect sweet, bitter, and umami stimuli and Type III cells detect bitter 
stimuli. The receptor for salt stimuli, which is a focus of the present study, has yet to be fully 
elucidated (Vandenbeuch, Clapp, & Kinnamon, 2008). It is thought that Type I cells express 
amiloride-sensitive pathways which are responsible for detection of salty stimuli. These work 
through the epithelial Na+ channel or ENaC. These ENaC are required for sodium ion transport 
across epithelial cells. Sodium salts are detected by direct permeation through apical ion 
channels, which depolarize the taste cell (Chaudhari & Roper, 2010). A different, amiloride-
insensitive pathway is responsible for distinguishing salts aside from NaCl with different cations 
and anions (Simon, de Araujo, Gutierrez, & Nicolelis, 2006). The amiloride-insensitive pathway 
is also thought to play a role in salt reception, and the nonselective cation channel TRPV1 has 
been implicated in this pathway. A study involving TRPV1 knockout mice indicated that while 
TRPV1 may be responsible for some aversion to NaCl, it is not the primary pathway involved in 
amiloride-insensitive NaCl taste (Ruiz, Gutknecht, Delay, & Kinnamon, 2006).  
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 The chorda tympani nerve, which innervates fungiform papilla, appears to contain at least 
two NaCl responsive fibers, N-Type and E-Type fibers. N-type fibers appear to be responsible 
for the amiloride sensitive transduction pathway as they are responsive to only NaCl and were 
inhibited by amiloride. E-Type fibers are responsive to various salts such as NaCl, KCl, and HCl 
and were not inhibited by amiloride. About 44% of taste cells in mice tested in one study were 
amiloride-sensitive, while 56% of cells were amiloride-insensitive (Yoshida et al., 2009).  
 Serotonin released from taste buds that acts on 5-HT3 receptors on nerve fibers has been 
proposed as the major taste neurotransmitter. However, a study in 2005 by Finger et al. refuted 
this hypothesis by testing the taste functionality of 5-HT3 knockout mice. 5-HT3 knockout mice 
did not show reduced taste signaling. Instead, ATP has been implicated as the key 
neurotransmitter involved in transducing taste signals (Finger et al., 2005). Salt taste still proves 
an anomaly, however, due to the lack of traditional synapses on Type I taste cells. This could be 
explained by cell-to-cell communication that occurs not only between the taste cells in each taste 
bud, but also is thought to occur between the different taste buds in the mouth. Since Type II 
taste cells lack traditional synapses, ATP is also thought to be involved in the cell-to-cell 
communication between Type II and Type III taste cells. (Huang et al., 2007). 
Background on cyclophosphamide 
While chemotherapy is often administered as part of a cocktail of drugs, 
cyclophosphamide (CYP) was one of the first developed chemotherapeutic agents and is still 
commonly prescribed. Its use includes treatment of leukemia, lymphoma, ovarian, and several 
other cancers (Mukherjee & Delay, 2011). CYP is a prodrug that acts as a DNA-alkylating agent 
once inside cells. It forms intra- or interstrand cross linkages in the DNA, which lead to 
irreparable DNA damage and ultimately apoptosis of the cell (Povirk & Shuker, 1994). Cells 
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with a high turnover rate are most susceptible to CYP attack, such as hair follicles and cells 
lining the intestine (Mukherjee & Delay, 2011). In clinical settings, chemotherapy is usually 
prescribed as a regimen administered on a weekly or monthly basis (DeVita & Chu, 2008). This 
is done to achieve a sustained concentration of the drug in the body, which can lead to more 
effective treatment (Bouchard-Fortier et al., 2016). 
Similar studies on cyclophosphamide and taste 
A past study of the gustatory system following CYP injection showed that umami taste 
acuity and sensitivity was affected in two phases. The first phase, which occurred 2-4 days post-
injection is likely due to cytotoxicity of the CYP on the fungiform taste buds. The second phase, 
which occurred 9-12 days post-injection is likely due to alteration of the cell replacement system 
(Mukherjee & Delay, 2011). Taste cells are typically replaced continually, and disturbance to the 
replacement cycle can lead to long-term taste deficiencies. This study shows that the complaints 
of altered taste by patients following chemotherapy are not entirely psychological, despite 
chemotherapy being known to cause long-term cognitive deficits (Ahles & Saykin, 2002). 
Mukherjee and Delay found that fungiform papillae are most affected after CYP injection, and 
do not begin recovering until day 12 (Mukherjee & Delay, 2011). Fungiform papillae are located 
in highest density on the anterior of the tongue and are innervated by the chorda tympani, which 
is associated with salt taste (Miller & Preslar, 1975). This gave us a further idea of the time-
frame in which salt taste is likely affected post CYP administration. 
 Patients who receive head and neck radiation, another common cancer treatment, also 
report altered taste. This is not surprising given that both chemotherapy and radiation affect 
rapidly dividing cells in the body, including taste cells. One proposed cause of this taste 
dysfunction is that irradiation can damage nerve fibers that innervate taste buds. A second cause 
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may be loss of salivary glands in the mouth, which could lead to lessened taste acuity. A study 
by Nguyen, Reyland, and Barlow in 2012 refuted both of these claims, stating that nerve fibers 
did not appear to be affected by radiation and that xerostomia is not likely to cause such severe 
taste alteration (Nguyen, Reyland, & Barlow, 2012). Consistent with the Mukherjee and Delay 
study, Nguyen et al. proposed that radiation affects progenitor cells responsible for supplying 
new cells to taste buds. Nguyen et al. also noted that cell loss is not immediately apparent due to 
the existing population of functional taste cells that are not affected by the radiation. However, 
after the aging population of functional taste cells are lost, they are not immediately replaced due 
to the damage on the progenitor cells caused by the radiation (Nguyen et al., 2012). This same 
mechanism likely also applies to chemotherapy due to the similar side effects of each treatment.  
Review of investigational methods used 
 Brief access testing (BAT) is a paradigm used in this study which allows high-
throughput testing of mice with altered gustatory function. This technique involves exposing 
mice to various concentrations of taste stimuli for brief periods of time and recording the 
numbers of times the mice lick each solution to study the preference for each stimuli 
(Glendinning, Gresack, & Spector, 2002). Conditioned taste aversion (CTA), a classical 
conditioning technique, is also used in this study. It involves pairing a conditioned stimulus (CS) 
with an unconditioned stimulus (US). The CS is typically a taste, while the US is usually lithium 
chloride (LiCl), which induces an upset stomach in mice. This causes the mice to avoid the CS in 
the future due to the expectation that CS and US are paired (Lin, Arthurs, & Reilly, 2014). 
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Study goals  
 The goal of the present study is to further understand the effects of CYP treatment on the 
perception of salty taste in mice. The first half of the study used a CTA model to pair NaCl taste 
with a LiCl injection to induce an aversion to NaCl. After a CYP injection, the aversion was 
evaluated for changes. The second half of the study used a simple BAT model to compare the 
different effects of a single CYP dose versus multiple CYP doses over several days to better 
replicate a clinical CYP administration. Generally, our hypothesis was that CYP treatment would 
affect Type I taste cells, leading to changes in salt preference. We further hypothesized that CYP 
treatment would reduce salt aversion. Lastly, we hypothesized that multiple doses over time 
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Chapter II: CTA Study  
Introduction 
 Conditioned taste aversion (CTA) methodology involves pairing a novel taste, known as 
the conditioned stimulus (CS), with a treatment, known as the unconditioned stimulus (US), 
which induces illness. Animals will then avoid the CS due to the assumption that the CS and the 
US are paired (Lin et al., 2014). CTA methodology can be useful in a range of studies, including 
evaluating the change in an aversion after a treatment. While conducting CTA work, it is 
important  to consider that a period of extinction occurs when an animal is exposed to only the 
CS and not the US, which causes the animal to lose the aversion (Hadamitzky, Bösche, Engler, 
Schedlowski, & Engler, 2015).  
 By inducing a CTA to NaCl in mice, then treating them with CYP, changes in the salt 
aversion afterwards can be used to infer the underlying cellular effects of CYP. The two different 
populations of Type I taste cells, one group with a lifespan of about 8 days and another with a 
life span of about 24 days, give us a time frame needed to fully evaluate how Type I taste cell 
populations change over time following CYP treatment (Perea-Martinez, Nagai, & Chaudhari, 
2013). Mukherjee and Delay found that CYP treatment lowers umami taste acuity and sensitivity 










 Two pilot studies were conducted to evaluate testing conditions for mice including ideal 
NaCl concentrations and length of testing sessions. Based on these studies, NaCl became 
naturally aversive between 175-300 mM, giving us a NaCl concentration range.  The following 
methods were based on those two studies and other relevant studies in the field. 
Subjects 
 Thirty-two male C57BL/6J mice obtained from Jackson Laboratory (Bar Harbor, ME, 
USA) were used in this study. Mice were housed in groups of four with their littermates, unless a 
mouse became sick, in which case it was moved to a separate solitary cage for treatment and 
observation. Mice were monitored by The University of Vermont veterinary technicians for the 
entirety of the study. The room was kept at 25° C and 60% humidity. Food pellets were provided 
ad libitum. All mice were ordered at six to eight weeks of age and allowed to acclimate to the 
room for at least one week. Mice were kept on a water deprivation schedule of 23 hours per day 
throughout the study which started one week before the beginning of the study. Mice were also 
handled during this initial water deprivation period to socialize them before experimentation. 
Any mouse that became too ill at any point in the experiment was immediately removed from the 
study and received veterinary attention. All mice were euthanized at the end of the study. All 
procedures were approved by The University of Vermont IACUC, protocol 10-038.  
Apparatus 
 Licks were monitored by computer-operated Davis Rig lickometers (DiLog Instruments, 
Tallahassee, FL, USA). Each Davis Rig consisted of a chamber (30cm x 15 cm x 23 cm) and a 
sliding block which could hold up to 16 glass tubes with lick spouts containing taste stimuli. 
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Tubes were filled with fresh NaCl solutions of varying concentrations and washed daily. The 
block containing the tubes ran based on a program on the computer. Each of the four Davis Rigs 
was separated from the other by a wooden box and a curtain, and pink noise was produced from 
a speaker in each box. Each tube was approximately 2mm behind a shutter. After a six second 
inter presentation interval period, the shutter opened and the mouse was given a chance to lick 
the solution for 7.5 seconds. Each time the mouse made contact with the metal lick spout, the 
computer recorded a lick. If the mouse did not lick a given solution, the shutter remained open 
until the mouse began to lick or the 20-minute time limit ran out.  
Davis Rig Habituation (5-7 days) 
 Mice were habituated to the Davis Rigs with water-only trials. Sessions started at 12pm 
daily and lasted 20 minutes. Water tubes were presented in the manner described above and 
would end after 20 minutes. Three water tubes were presented in a randomized order to allow the 
mice to habituate to the movement of the block.  Habituation continued until mice were 
consistently licking, which on average took five days.  
Conditioning (5-7 days) 
 Half of the mice were conditioned to avoid NaCl. Mice were presented with 25, 50, 100, 
175, and 300 mM NaCl solutions along with two water tubes in a randomized order. Two 
random water trials from each mouse on each day were averaged giving us a “0 mM NaCl” 
water rinse value. Latin-Square procedures were used to generate random tube sequences. Each 
trial began with four presentations of water, which acted as a rinse for the mice. Immediately 
following the twenty minute sessions, the conditioned mice were injected intraperitoneally with 
225 mM LiCl (1mL/kg) dissolved in bacteriostatic water to induce an upset stomach, leading to 
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an aversion to NaCl. The remaining mice acted as a control and were injected with saline 
(1ml/kg) which does not induce an aversion. This process was repeated daily at 12pm until LiCl 
mice showed a clear aversion to NaCl. An aversion was identified as a NaCl lick rate for each 
mouse of <40% when compared to the water licks for that mouse.  
Cyclophosphamide Injection 
 Mice were taken off water deprivation for 24 hours to rehydrate them in preparation for 
CYP injection. At 12pm the following day, half of the LiCl mice and half of the control mice 
were injected intraperitoneally with 100 mg/kg CYP, and the remaining mice received a saline 
injection. 24 hours later, the mouse cages were changed to prevent them from becoming ill due 
to the toxic CYP byproducts secreted in urine after injection. At this time, the mice were also 
returned to a 23-hour water deprivation schedule so that testing could begin the following day. 
NaCl Testing (20-25 Days) 
 Next, mice were presented with the same 25, 50, 100, 175, and 300 mM NaCl solutions 
as described above in the conditioning step. About an hour after each session, the mice were 
given water bottles for approximately five minutes to rehydrate after the high salt intake during 
the session.  
 
Statistical Methods 
 Lick rates were normalized by dividing the mean lick count for each concentration of 
NaCl by the mean lick count for the water trials. This step was taken to ensure that variable 
motivational states between mice was accounted for in our analysis. Some graphs show 
  Michael Gomella 
13 
 
normalized lick rates on a 100-point scale, which is the previously described normalized lick rate 
multiplied by 100. Any mouse who did not get through at least one presentation of each NaCl 
concentration on any given day would have its data excluded for that day. The sample size of 
each group was eight from day 2-21. From day 22-25, the sample size for all groups was four. 
This is due to a decision to run the second group of mice longer to ensure all CYP effects were 
observed in the study time frame.   
Ensuring proper condition before testing 
 CTA was considered successful when LiCl injected mice show significantly fewer licks 
than control mice. A 2 (US) x 5 (Five concentrations of NaCl) mixed factorial analysis was used 
to analyzed the lick rates for each group of mice. These were computed using IBM SPSS 
Statistics 23 software.  
Changes in salt preference following injection 
 Our analysis used a mixed factorial design, with two treatment condition states (Saline 
and LiCl) by two drug states (CYP and Control) as subject variables. Within the subject 
variables, there were five concentrations (25, 50, 100, 175, and 300 mM NaCl) and 25 days. 
Because of the large number of days, data were partitioned for specificity and ease of analysis. 









Pre-CYP group differences 
 Pre-CYP injection group differences between both groups of LiCl mice were not 
significant for any concentration of NaCl. Pre-CYP injection group differences between both 
groups of non-conditioned mice were not significant for any concentration of NaCl (p>0.05).  
Did the CYP have an effect on NaCl licks? 
 A condition state (LiCl or Saline) by drug state (CYP or Saline) by day analysis revealed 
significantly higher licks for mice who received CYP compared to control mice at 50, 100, 175, 
and 300 mM NaCl as seen in Table 1 (p <0.005). The effect of the drug for 25 mM NaCl was not 
significant. Graphs of each concentration over days are shown in Figures 1-6. The drug state by 
day interaction was not statistically significant for any concentration.  
 
 










Control 25 0.800 0.027 (1,149) = 
2.80 
0.371 
CYP 0.834 0.026 
Control 50 0.684 0.025 (1,151) = 
0.81 
0.017 
CYP 0.768 0.024 
Control 100 0.614 0.025 (1,143) = 
7.68 
0.006 
CYP 0.708 0.024 
Control 175 0.532 0.025 (1,133) = 
27.15 
<0.001 
CYP 0.712 0.024 
Control 300 0.499 0.031 (1,108) = 
18.80 
<0.001 
CYP 0.686 0.030 
 Table 1: Condition state by drug state by day analysis comparing the control group and the CYP 
group. CYP mice show significantly higher lick rates for 50, 100, 175, and 300 mM NaCl.  
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Figure 1: Normalized lick rates over days for 25 mM NaCl. The upper graph shows mice that were not conditioned 
to avoid NaCl, while the lower graphs shows mice that were conditioned to avoid NaCl. No significant drug effects 
are seen in the Saline/Saline vs. Saline/CYP conditions (p>0.05), seen in the upper graph, or the LiCl/CYP vs. 
LiCl/Saline conditions (p>0.05), seen in the lower graph. 
  Michael Gomella 
16 
 






















S a lin e
 






















S a lin e
  
Figure 2: Normalized lick rates over days for 50 mM NaCl. The upper graph shows mice that were not conditioned 
to avoid NaCl, while the lower graphs shows mice that were conditioned to avoid NaCl. CYP mice licked 
significantly more than control mice Saline/Saline vs. Saline/CYP conditions (p = 0.002), seen in the upper graph. 
There were no significant drug effects between the LiCl/CYP vs. LiCl/Saline conditions (p >0.05), seen in the lower 
graph.  
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Figure 3: Normalized lick rates over days for 100 mM NaCl. The upper graph shows mice that were not conditioned 
to avoid NaCl, while the lower graphs shows mice that were conditioned to avoid NaCl. CYP mice licked 
significantly more than control mice Saline/Saline vs. Saline/CYP conditions (p = 0.003), seen in the upper graph. 
There were no significant drug effects between the LiCl/CYP vs. LiCl/Saline conditions (p>0.05), seen in the lower 
graph.  
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Figure 4: Normalized lick rates over days for 175 mM NaCl. The upper graph shows mice that were not conditioned 
to avoid NaCl, while the lower graphs shows mice who that were conditioned to avoid NaCl. CYP mice licked 
significantly more in the Saline/Saline vs. Saline/CYP conditions, (p = 0.001), seen in the upper graph, and the 
LiCl/CYP vs. LiCl/Saline conditions (p <0.001), seen in the lower graph.  
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Figure 5: Normalized lick rates over days for 175 mM NaCl. The upper graph shows mice that were not conditioned 
to avoid NaCl, while the lower graphs shows mice that were conditioned to avoid NaCl. CYP mice licked 
significantly more in the Saline/Saline vs. Saline/CYP conditions, (p = 0.001), seen in the upper graph, and the 
LiCl/CYP vs. LiCl/Saline conditions (p =0.011), seen in the lower graph.  
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Non-conditioned vs. Conditioned Mice 
To confirm proper conditioning, the NaCl lick rates of LiCl mice were compared to the 
NaCl lick rates of non-conditioned mice. LiCl mice showed significantly fewer licks for 100 mM 
NaCl, F(1, 143) = 18.19, p <0.001, 175 mM NaCl, F(1, 133) = 60.54, p <0.001, and 300 mM, 
F(1, 108) = 71.60, p <0.001, when compared to non-conditioned mice.  
A drug state by day analysis revealed that non-conditioned mice who received CYP had 
significantly higher lick rates across more NaCl concentrations than LiCl mice when compared 
to control mice. Non-conditioned, CYP mice showed significantly higher lick rates for 25, 50, 
100, 175, and 300 mM NaCl compared to control mice, seen in Table 2. LiCl, CYP mice showed 















p (Bolded if 
<0.05) 
Saline Control 25 0.770 0.041 (1,67) = 
2.74 
0.103 
CYP 0.862 0.038 
Saline Control 50 0.682 0.033 (1,80) = 
10.20 
0.002 
CYP 0.824 0.030 
Saline Control 100 0.666 0.032 (1,75) = 
9.36 
0.003 
CYP 0.801 0.030 
Saline Control 175 0.653 0.045 (1,59) = 
11.56 
0.001 
CYP 0.860 0.041 
Saline Control 300 0.669 0.047 (1,58) = 
11.38 
0.001 
CYP 0.883 0.043 
 Table 2: Drug state by day analysis comparing the control group and the CYP group in the non-conditioned state. 
CYP mice showed significantly higher lick rates for 50, 100, 175 and 300 mM NaCl.  
  
  




Specific days of interest 
A condition state by drug state by concentration analysis done on each individual day 
revealed certain days when drug effects were significant to test if there was a CYP effect pattern 
or cycle. CYP mice shower significantly higher lick rates compared to control mice on days 5, 6, 
7, 9, 11, 13, seen in Table 4 and Figure 7. No significant drug effects were seen on days 14-18, 
then CYP mice again showed significantly higher lick rates on day 19 seen in Figure 8. Drug 
















p (Bolded if 
<0.05) 
LiCl Control 25 0.830 0.036 (1,82) = 
0.230 
0.633 
CYP 0.806 0.036 
LiCl Control 50 0.688 0.037 (1,72) = 
0.170 
0.681 
CYP 0.710 0.037 
LiCl Control 100 0.563 0.036 (1,69) = 
0.979 
0.326 
CYP 0.614 0.036 
LiCl Control 175 0.411 0.026 (1,18) = 
17.50 
<0.001 
CYP 0.565 0.026 
LiCl Control 300 0.328 0.042 (1,48) = 
7.09 
0.011 
CYP 0.487 0.042 
 
Table 3: Drug state by day analysis comparing the control group and the CYP group in the LiCl conditioned state. CYP 
mice showed significantly higher lick rates for 175 and 300 mM NaCl.  
  
  











p (Bolded if 
<0.05) 
Control 5 0.590 0.064 (1,37) = 
5.81 
0.021 
CYP 0.879 0.062 
Control 6 0.583 0.049 (1,33) = 
8.20 
0.007 
CYP 0.779 0.048 
Control 7 0.539 0.057 (1,33) = 
5.37 
0.027 
CYP 0.719 0.053 
Control 9 0.698 0.035 (1,44) = 
5.43 
0.024 
CYP 0.815 0.036 
Control 11 0.597 0.042 (1,43) = 
5.85 
0.020 
CYP 0.740 0.042 
Control 13 0.538 0.046 (1,114) = 
10.30 
0.021 
CYP 0.691 0.044 
Control 19 0.612 0.049 (1,42) = 
5.90 
0.019 
CYP 0.778 0.048 
 Table 4: Condition state by drug state by concentration analysis comparing control mice and CYP mice. CYP 
mice showed significantly higher lick rates on days 5, 6, 7, 9, 11, 13, and 19. No significant drug effect was 
seen on the other days.  
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Figure 6: Normalized lick rates for days 4-13. Non-conditioned mice have dotted lines, while LiCl, conditioned mice 
have solid lines. Drug state control mice (saline) have bolded lines. CYP mice had significantly higher lick rates on 
days 5, 6, 7, 9, 11, and 13 (p<0.05). Days 4, 8, 10, and 12 were included for comparison. 
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Figure 7: Normalized lick rates for days 18-20. Non-conditioned mice have dotted lines, while LiCl, conditioned 
mice have solid lines. Drug state control mice (saline) have bolded lines. CYP mice had significantly higher lick 
rates on day 19 (p =0.019). Days 18 and 20 were included for comparison. 
 
 A drug state by day analysis of conditioned LiCl mice revealed that LiCl mice had no 
significant drug effects on any day. In contrast, non-conditioned, CYP injected mice showed 
significantly higher lick rates compared to control mice on days 5, 6, 7, 9, 13, and 14, seen in 
Table 5 and in Figure 6. Significant drug effects were not seen again until day 19, when non-
conditioned CYP mice had significantly higher lick rates compared to controls, seen in Figure 7. 




 In summary, CYP mice showed significantly higher lick rates compared to control mice 
at 50, 100, 175, and 300 mM NaCl. Non-conditioned mice showed significantly higher lick rates 
compared to control mice at more NaCl concentrations than LiCl mice. CYP mice showed 
significantly higher lick rates compared to control mice on days 5, 6, 7, 8, 11, and 19. 
 
Discussion 
 In this study, we attempted to use CTA methodology to evaluate the effect of CYP on salt 
taste in mice. We hypothesized that CYP treatment would affect Type I taste cells, leading to 
changes in salt preference. We also hypothesized that CYP treatment would reduce salt aversion.  
CYP injected LiCl mice, who were conditioned to avoid NaCl, generally showed higher 
lick rates for both 175 mM and 300 mM compared to the control group throughout the study. 
Higher licks rates indicate reduced aversion, which supports our reduced aversion hypothesis. 
Condition 
State 







Saline Control 5 0.689 0.109 (1,18) = 
9.23 
0.007 
CYP 1.143 0.102 
Saline Control 6 0.679 0.070 (1,15) = 
0.910 
0.009 
CYP 0.976 0.070 
Saline Control 7 0.682 0.059 (1,20) = 
4.52 
0.046 
CYP 0.848 0.051 
Saline Control 9 0.750 0.074 (1,15) = 
5.60 
0.032 
CYP 0.991 0.070 
Saline Control 13 0.541 0.065 (1,21) = 
11.45 
0.003 
CYP 0.844 0.061 
Saline Control 14 0.660 0.057 (1,21) = 
6.56 
0.018 
CYP 0.861 0.054 
Saline Control 19 0.581 0.079 (1,20) = 
6.13 
0.022 
CYP 0.850 0.074 
 Table 5: Drug state by day analysis comparing non-conditioned mice and control mice. CYP mice showed 
significantly higher lick rates on days 5, 6, 7, 9, 13, 14, and 19.  
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However, mice that were not conditioned to avoid NaCl and that were treated with CYP showed 
significantly higher NaCl lick rates at more concentrations than the LiCl mice when compared to 
the control group. These non-conditioned CYP mice showed significantly higher lick rates at 50, 
100, 175, and 30 mM NaCl. This discrepancy could be explained by the presence of TRPV1 
which has been proposed to be involved with aversion to NaCl (Ruiz et al., 2006). CYP may be 
affecting Type I taste cells, but if a secondary salt taste cell type is unaffected by CYP, an 
aversion would still remain after treatment. TRPV1 cells, which may be involved with NaCl 
aversion, may not be sensitive to CYP treatment.  Even though TRPV1 are not the predominate 
secondary salt reception cell, the second population of salt receptor cells could have a vastly 
different life span than Type I taste cells (Ruiz et al., 2006). A second possibility for why LiCl 
mice showed drug effects at fewer concentrations could involve this difference in life span. We 
know that CYP mainly affects dividing cells (Mukherjee & Delay, 2011). By the time the 
amiloride-insensitive cells need to be replaced by CYP damaged progenitor cells, the aversion to 
NaCl could be extinct. This secondary disturbance could explain the day 19 significant drug 
effect seen in LiCl mice in Figure 5.   
Still, non-conditioned mice who received CYP injections showed significantly higher lick 
rates for most of the concentrations of NaCl. Both preliminary pilot studies and our saline only 
control groups indicate that NaCl becomes naturally aversive between 175 and 300 mM. Our 
data suggest that drug effects start around day 5 post-CYP treatment and continue to around day 
13, then occur again around day 19. This two-phase disturbance could coincide with the different 
life spans of Type I taste cells, three-fourths of which have a half-life of eight days, while the 
other live for 24 days (Perea-Martinez et al., 2013).  
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Chapter III: Multiple vs. One Dose of CYP 
Introduction  
 Results from our CTA study indicate that LiCl, CYP mice did not show as many 
concentrations of significance compared to non-conditioned mice. For this reason, the CTA 
aspect of our next study was removed and replaced with a simple BAT paradigm, where mice are 
exposed to taste solutions for a short period of time without LiCl injections. Due to the interest in 
a secondary salt receptor cell population, we developed a methodology aimed at disturbing 
multiple salt receptor cell types (Yoshida et al., 2009). 
 Preliminary molecular studies in our lab indicate that multiple CYP injections over days 
could disturb multiple salt receptor cell populations. This would more closely replicate 
chemotherapy regimens that are used in a clinical setting (DeVita & Chu, 2008). Thus, a study 
involving both multiple and single injection mice may help to elucidate not only the overall 
effect that CYP has on salt taste, but also uncover the CYP sensitivity of other salt sensitive cell 
types as well. We hypothesized that multiple CYP doses over time would affect multiple salt 




 Thirty-one male C57BL/6J mice obtained from Jackson Laboratory (Bar Harbor, ME, 
USA) were used in this study. Mice were housed in groups of four with their littermates, unless a 
mouse became sick in which case it was moved to a separate solitary cage for treatment and 
observation. Mice were monitored by The University of Vermont veterinary technicians for the 
entirety of the study. The room was kept at 25° C and 60% humidity. Food pellets were provided 
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ad libitum. All mice were ordered at six to eight weeks of age and allowed to acclimate to the 
room for at least one week. Mice were kept on a water deprivation of 23 hours throughout the 
study which started one week before the beginning of the study. Mice were also handled during 
this initial water deprivation period to socialize them before experimentation. Any mouse that 
became too ill at any point in the experiment was immediately removed from the study and 
received veterinary attention. All mice were euthanized at the end of the study. All procedures 
were approved by The University of Vermont IACUC, protocol 10-038.  
Apparatus 
 Licks were monitored by computer-operated Davis Rig lickometers (DiLog Instruments, 
Tallahassee, FL, USA). Each Davis Rig consisted of a chamber (30cm x 15 cm x 23 cm) and a 
sliding block which could hold up to 16 glass tubes with lick spouts containing taste stimuli. 
Tubes were filled with fresh NaCl solutions of varying concentrations and washed daily. The 
block containing the tubes ran based on a program on the computer. Each Davis Rig was 
separated from the other by a wooden box and a curtain, and pink noise was produced from a 
speaker in each box. Each tube was approximately 2mm behind a shutter. After a 6 second inter 
presentation interval period, the shutter opened and the mouse was given a chance to lick the 
solution for 7.5 seconds. Each time the mouse made contact with the metal lick spout, the 
computer recorded a lick. If the mouse did not lick a given solution, the shutter remained open 
until the mouse began to lick or the 20-minute time limit ran out.  
Davis Rig Habituation (5-7 days) 
 Mice were habituated to the Davis Rigs with water-only trials. Sessions started at 12pm 
daily and lasted 20 minutes. Water tubes were presented in the manner described above and 
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would end after 20 minutes. Three water tubes were presented in a randomized order to allow the 
mice to habituate to the movement of the block.  Habituation continued until mice were 
consistently licking, which on average took five days.  
Initial NaCl Presentation (~5 Days) 
 Mice were presented with 50, 100, 175, and 300 mM NaCl solutions along with two 
water tubes in a randomized order. Sucrose (100 mM), which is typically licked at a higher rate 
than water by mice, was also included in the sequence to test for neophobia (the fear of new 
things). Latin-Square procedures were used to generate random tube sequences. Each trial began 
with four presentations of water which acted as a rinse for the mice. This process was repeated 
daily at 12pm until mice showed a consistent NaCl licking pattern. This typically took about 5 
days.  
Cyclophosphamide Injection 
 Mice were taken off water deprivation for 24 hours to rehydrate them in preparation for 
CYP injection. One third of the mice were assigned multiple injections, another third were 
assigned a single injection, and the remaining mice acted as control mice who received saline 
injections. At 12pm the following day, the multiple injection mice received a 20 mg/kg dose of 
CYP intraperitoneally and the remaining mice received the same volume of saline. This 
continued for five days, and on the fifth day, the multiple injection mice received a 20 mg/kg 
dose as before, the single injection mice received one 100 mg/kg intraperitoneal CYP injection, 
and the control mice received a saline injection of the same volume as the other mice. 24 hours 
later, the mouse cages were changed to prevent them from becoming ill due to the toxic CYP 
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byproducts secreted in urine after injection. At this time, the mice were also returned to the 23-
hour water deprivation schedule so that testing could begin the following day. 
NaCl Testing (31 Days) 
 Next, mice were presented with the same 50, 100, 175, and 300 mM NaCl and 100 mM 
sucrose solutions as described above in the initial NaCl presentation step. An hour after each 
session, the mice were given water bottles for approximately five minutes to rehydrate due to the 
high salt intake during the session. 
 
Statistical Methods 
 Lick rates were normalized by dividing the mean lick count for each concentration of 
NaCl by the mean lick count for the water trials. This step was taken to ensure that variable 
motivational states between mice was accounted for in our analysis. Some graphs show 
normalized lick rates on a 100-point scale, which is the previously described normalized lick rate 
multiplied by 100. Any mouse who did not get through at least one presentation of each NaCl 
concentration on any given day would have its data excluded for that day. The number of mice in 
each group is 10 from days 2-15. The remaining mice are still being run, so the number of mice 
from day 16-31 is only five.  
Changes in salt preference following injection 
 Our analysis used a mixed factorial design, with two injection states (Single or multiple) 
by two drug states (CYP and Control) as subject variables. Within the subject variables, there 
were four concentrations (50, 100, 175, and 300 mM NaCl) and 31 days. Because of the large 
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number of days, data were partitioned for specificity and ease of analysis. Averages of lick rates 
for each concentration on each day for each mouse were used in the following analyses. These 
analyses were done using IBM SPSS Statistics 23 software.  
 
Results 
Pre-CYP group differences 
 Before CYP injection, group differences between the three conditions were not 
significant for any concentration of NaCl (p>0.05). 
Neophobia (Fear of new things) 
 All mice had mean lick rates for 100 mM sucrose that exceeded mean water lick rates. 
The average for all mice was a normalized lick rate of 142% compared to water.  
Drug effects 
 In a drug condition (CYP or Control) by day analysis, CYP injected mice had higher 
normalized lick rates compared to control mice for 175 mM NaCl, seen in Table 6. The drug 
state by day interaction was also significant for 175 mM NaCl, F(29, 321) = 1.51, p = 0.048, but 
not for any other concentration.  




Multiple Doses vs. Single Dose 
 A dosage by day analysis revealed that there was no significant difference in lick rates for 
mice who received a single CYP injection compared to mice who received multiple CYP 
injections at any concentration, seen in Table 7. 
 
 Single CYP injection mice showed significantly higher lick rates compared to control 
mice at 175 mM, shown in Table 8 and Figure 8. Multiple CYP injection mice showed 
significantly higher lick rates compared to control mice at 175 mM, seen in Table 9 and Figure 8.   








p (Bolded if 
<0.05) 
Control 50 0.680 0.027 (1,169) = 
0.21 
0.649 
CYP 0.695 0.016 
Control 100 0.649 0.026 (1,165) = 
0.174 
0.677 
CYP 0.661 0.016 
Control 175 0.577 0.025 (1,162) = 
6.75 
0.010 
CYP 0.651 0.015 
Control 300 0.735 0.031 (1,140) = 
0.13 
0.724 
CYP 0.722 0.018 
 
Table 6: Drug state by day analysis comparing the control mice and CYP injected mice. CYP 













Single 50 0.697 0.022 (1,123) = 
0.02 
0.897 
Multiple 0.693 0.020 
Single 100 0.661 0.024 (1,107) = 
0.00 
0.952 
Multiple 0.663 0.021 
Single 175 0.648 0.022 (1,111) = 
0.08 
0.774 
Multiple 0.656 0.020 
Single 300 0.695 0.026 (1,96) = 
2.08 
0.153 
Multiple 0.746 0.024 
 
Table 7: Dosage by day analysis comparing the single CYP injection group and the multiple CYP 
injection group. The group differences were not significant at any concentration.   
  
  Michael Gomella 
33 
 





















C o n tro l
S in g le  D o s e





















C o n tro l
M u ltip le  D o s e s
 
Figure 8: Normalized lick rates over days for 175 mM NaCl. The upper graph shows single CYP dose mice 
compared to control mice, while the lower graph shows multiple CYP dose mice compared to control mice. Both 
single injection mice and multiple injection mice showed significantly higher lick rates overall when compared to 
control mice at 175 mM NaCl (p<0.05).  
 





Specific Days of Interest 
 A drug state by concentration analysis performed on each individual day revealed days of 
interest. Mice injected with CYP showed significantly higher lick rates compared to control mice 
on days 3, 5, 8, and 18, seen in Table 10. Control mice showed significantly higher lick rates 









p (Bolded if 
<0.05) 
Control 50 0.680 0.028 (1,98) = 
0.19 
0.665 
Single 0.696 0.025 
Control 100 0.648 0.027 (1,96) = 
0.95 
0.759 
Single 0.660 0.024 
Control 175 0.577 0.024 (1,95) = 
4.80 
0.031 
Single 0.647 0.022 
Control 300 0.734 0.029 (1,82) = 
1.03 
0.313 
Single 0.695 0.026 
 Table 8: Dosage by day analysis comparing the control group and single CYP injection group. 










p (Bolded if 
<0.05) 
Control 50 0.681 0.029 (1,105) = 
0.11 
0.745 
Multiple 0.693 0.024 
Control 100 0.649 0.027 (1,108) = 
0.00 
0.688 
Multiple 0.663 0.022 
Control 175 0.577 0.025 (1,111) = 
6.10 
0.015 
Multiple 0.656 0.020 
Control 300 0.734 0.032 (1,93) = 
0.08 
0.783 
Multiple 0.746 0.026 
 
Table 9: Dosage by day analysis comparing the control group and multiple CYP injection group. 
Multiple injection mice showed significantly higher lick rates for 175 mM NaCl.  
  




 Single CYP injection mice showed significantly higher NaCl lick rates when compared to 
control mice on days 2, 8, and 18, as seen in Table 11 and Figures 9-11. Control mice showed 
significantly higher lick rates on day 22. Multiple injection mice showed significantly higher 
NaCl lick rates when compared to control mice on days 8, 9, and 18, as seen in Table 12 and 
Figures 10 and 11. Control mice showed significantly higher lick rates on day 22.  
  
 





p (Bolded if 
<0.05) 
Control 3 0.866 0.056 (1,49) = 
7.51 
0.009 
CYP 1.046 0.034 
Control 5 0.769 0.048 (1,48) = 
4.98 
0.030 
CYP 0.895 0.030 
Control 8 0.812 0.065 (1,60) = 
7.61 
0.008 
CYP 1.026 0.042 
Control 18 0.479 0.060 (1,22) = 
11.17 
0.003 
CYP 0.715 0.036 
Control 22 1.136 0.063 (1,28) = 
8.01 
0.009 
CYP 0.926 0.038 
 Table 10: Drug state by concentration analysis comparing the control group and the CYP groups. CYP 
mice showed significantly higher lick rates on days 3, 5, 8, and 18. Control mice showed significantly 
higher lick rates on day 22.  
  





p (Bolded if 
<0.05) 
Control 2 0.768 0.054 (1,29) = 
6.18 
0.019 
Single 0.948 0.048 
Control 8 0.747 0.086 (1,20) = 
5.57 
0.029 
Single 1.045 0.092 
Control 18 0.300 0.068 (1,8) = 
10.22 
0.012 
Single 0.594 0.061 
Control 22 1.118 0.058 (1,17) = 
11.41 
0.003 
Single 0.857 0.052 
 
Table 11: Drug state by concentration analysis comparing the control group and single CYP 
injection group. Single injection mice showed significantly higher lick rates on days 2, 8, and 
18. Control mice showed significantly higher lick rates on day 22.  
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Figure 9: Normalized lick rates for days 2 and 3. Single injection mice had significantly higher lick rates compared 
to control mice on day 2 (p =0.019). Day 3 was included for comparison. 





p (Bolded if 
<0.05) 
Control 8 0.747 0.064 (1,31) = 
6.57 
0.015 
Multiple 0.957 0.052 
Control 9 0.506 0.061 (1,23) = 
4.73 
0.040 
Single 0.679 0.050 
Multiple 18 0.300 0.058 (1,14) = 
16.74 
0.001 
Single 0.606 0.047 
Control 22 1.118 0.062 (1,17) = 
11.41 
0.003 
Multiple 0.846 0.050 
 
Table 12: Drug state by concentration analysis comparing the control group and multiple CYP 
injection group. Multiple injection mice showed significantly higher lick rates on days 8, 9, and 
18. Control mice showed significantly higher lick rates on day 22.  
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Figure 10: Normalized lick rates for days 7, 8, 9 and 10. Single injection and multiple injection mice had 
significantly higher lick rates compared to control mice on day 8, and multiple injection mice had significantly 
higher lick rates compared to control mice on day 9. Days 7 and 10 were included for comparison. 
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Figure 11: Normalized lick rates for days 18, 19, 20, 21, and 22. Single injection and multiple injection mice had 
significantly higher lick rates compared to control mice on day 18. Control mice had significantly higher lick rates 
on compared to multiple and single injection mice on day 22. Days 19-21 were included for comparison. 
 
 
 In summary, CYP mice showed significantly higher lick rates compared to control mice 
at 175 mM NaCl and on days 8, 9, and 18. There were no significant differences between single 
CYP dose and multiple CYP dose mice for any concentration.   




 In this study, we attempted to determine the different effects on salt taste of a single dose 
of CYP compared to multiple doses of CYP spread out over five days. Our hypothesis was that 
CYP treatment would affect Type I taste cells, leading to changes in salt preference. We further 
hypothesized that multiple doses over time would affect multiple salt receptor cell types leading 
to more significant changes in salt preference. While we found significant CYP effects on the 
lick rates of NaCl, we did not see any significant difference in lick rates between single injection 
mice and multiple injection mice.  
 Since both the single and multiple injection groups of mice received an overall dosage of 
100 mg/kg CYP, the lack of difference between groups could indicate that dose volume has more 
influence than the timing of the dose. That being said, the CYP mice showed a significantly 
higher lick rate compared to control mice at 175 mM NaCl. This significance, however, may not 
necessarily be a result of CYP. The control mean lick rate at 175 mM NaCl is lower than it is at 
other concentrations, including 300 mM, which was unexpected due to the natural NaCl aversion 
at 300 mM. Figure 8 illustrates this low lick rate for control mice not seen at other 
concentrations. This could be attributed to the small overall sample size for the control group, 
especially for days 15-31. Re-running these analyses after the present group of mice is completed 
may be beneficial and help to clarify these results.  
 All mice licked the 100 mM sucrose at rates that exceeded water, indicating that fear of 
new tastes (neophobia) did not influence our results. We saw significantly higher licks in both 
CYP groups compared to control mice on days 8 and 18. This range is fairly consistent with the 
proposed life span of the two different populations of Type I taste cells discussed by Perea-
Martinez et al. (2013) which are eight days for one sub-population and 24 days for the second 
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sub-population (Perea-Martinez et al., 2013). The observed second disturbance is off from the 
proposed value in their paper, but our study still supports that there are two sub populations with 
differing life spans.  
We expected to see significant group differences at 300 mM based on our CTA study, but 
this was absent for all comparisons made. This could be attributed to individual NaCl preference 
in the mice tested. The general avoidance curve we expected to see in control mice was absent 
for most days, and control mice seemed to prefer 300 mM NaCl.  
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Chapter IV: General Discussion 
 This paper describes our experience with two techniques to examine the effects of CYP 
on salt taste in mice. The first study used a conditioned taste aversion (CTA) study to test if 
aversion to NaCl changed after CYP treatment. The second used a simple brief access test (BAT) 
to compare the different effects of a single CYP injection and multiple CYP injections over five 
days. Generally, our hypothesis was that CYP treatment would affect Type I taste cells, leading 
to changes in salt preference. We further hypothesized that CYP treatment would reduce salt 
aversion. Lastly, we hypothesized that multiple CYP doses over time would affect multiple salt 
receptor cell types leading to more significant changes in salt preference. 
Common Effects of CYP  
 In both studies, CYP treated mice showed significantly higher lick rates than control mice 
for at least one NaCl concentration. The drug effect was significant at more concentrations in the 
CTA study, while 175 mM NaCl was the only concentration where significant drug effects were 
seen in the second study. As stated in Chapter III, a larger sample size could be beneficial in both 
studies to mitigate the differences in individual mouse licking patterns. Still, the differences seen 
in the CTA study are enough to conclude that CYP does affect the NaCl taste receptor pathway. 
Since there were significantly higher licks for CYP mice than control mice in both studies, it can 
be assumed that CYP affects multiple salt receptor cell types. The individual level at which each 
is affected, however, is impossible to determine given our results. The goal of the second study 
was to affect the multiple pathways with multiple CYP injections over days. Since there were no 
differences between the single injection group and the multiple injection group, we were likely 
unsuccessful in affecting other salt receptor cell types with multiple injections. These results also 
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demonstrate that multiple injection CYP regimens do not necessarily have more severe taste 
related side effects than single dose CYP treatment, although the side effects may last the length 
of the treatment regimen. 
Mice conditioned to avoid NaCl did not show significant drug effects at as many 
concentrations as non-conditioned mice. This could indicate that a CYP insensitive pathway 
remains unaffected, or affected in a different time frame. A study by Ruiz et al. indicated that 
while the TRPV1 receptor is not the main secondary salt taste receptor, it could be involved in 
some NaCl aversion (Ruiz et al., 2006). Studies have indicated that TRPV1 channels play an 
important role in DNA repair following radiation damage to DNA. For this reason, it would be 
beneficial for TRPV1 channels to be protected from damage caused by exterior agents such as 
CYP or radiation (Masumoto, Tsukimoto, & Kojima, 2013). These protected NaCl taste cells 
may be responsible for the continued aversion to low concentration NaCl following CYP 
treatment.  
Timing of CYP Effects 
 In both the CTA and BAT studies, CYP mice showed significantly higher lick rates 
during the same time periods post-CYP injection. This range spanned from days 5-9 and days 
18-19. A study by Perea-Martinez et al. (2013) proposed that Type I taste cells have two sub-
populations, one with a life span of eight days and another with a life span of 24 days. The cells 
that have a life span of eight days are proposed to be mature cells, while the cells with a life span 
of 24 days are thought to be immature cells that mature and differentiae to become Type I cells 
(Perea-Martinez et al., 2013). Our study supports the finding of an initial eight-day life span of 
mature Type I cells given that this was the time period that the first NaCl taste disturbance 
occurred in our CYP mice. The secondary disturbance noted, which occurred around day 18, 
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could be the second population described as “immature Type I cells.” However, since our day 18 
disturbances were several days off from the proposed second disturbance, this could indicate that 
a different taste cell type is being affected. Another cell type could have a different life span than 
Type I taste cells, and this second cell type could be responsible for the second, day 18 
disturbance.  
Another explanation could involve the replacement cycle for the cells.  Nguyen et al. 
proposed that patients treated with head and neck radiation see a delayed disturbance after 
treatment due to the disturbance of the cell replacement cycle (Nguyen et al., 2012). After mature 
cells die, progenitor cells replace them. However, if the CYP is affecting progenitor cells, the 
dead cells are not replaced, leading to an alteration in taste later in time.   
 A study by Mukherjee and Delay in 2011 showed that umami taste was affected by CYP 
in two phases. They saw a disturbance at days 2-4 and days 9-12, which is slightly different than 
the biphasic disturbance that we saw when studying NaCl taste. This is likely due to the different 
receptors involved in salt taste and umami taste. The two phases seen in both the present study 
and their study suggest that biphasic taste disturbances are typical for CYP treated mice. 
Mukherjee and Delay also noted that fungiform papillae were most affected by CYP treatment 
and did not begin to recover until day 12. While we did not see the disturbance on days 2-4 that 
they observed, we did have residual CYP affects that persisted during the first disturbance to day 
13. This could be indicative of the fungiform recovery period discussed by Mukherjee and Delay 
(Mukherjee & Delay, 2011). 
 This secondary disturbance can also be explained by an entirely different mechanism. 
The body is able to compensate for lost cell types by upregulating other pathways and speeding 
up differentiation of other cell types, as hypothesized by Ruiz et al. in their study of TRPV1 
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knockout mice (Ruiz et al., 2006). By disrupting Type I taste cells with CYP, it is possible that 
the 24-day life span of the secondary population of taste cells was sped up and these cells 
differentiated quicker to compensate for the cells lost during CYP treatment. This could explain 
the day 18-19 disturbance that we saw and explain why it did not occur on day 24 as predicted.  
CTA vs. BAT study 
 As discussed above, the CTA study mice showed significant drug effects on more days 
and at more concentrations of NaCl than the BAT study mice. This difference could be attributed 
to differences between mouse litters involved in each study. The control animals for the BAT 
study did not have consistent data with the controls from the CTA study, which was unexpected 
due to the similar experimental conditions. An aberrant control group could have confounded our 
results for the second study. This problem will likely be mitigated once more mice complete the 
study, and a second control group is factored into the analyses. 
Taste Study Criticisms 
 A criticism of taste studies is ensuring that animals use only the taste cue to identify the 
solution and its concentration. Since mice are obligatory smellers, many of their sensory cues 
come from the scents they perceive (Spector, 2003). While no control for scent was used in this 
study, the BAT paradigm is designed to minimize olfactory effects on taste since mice are 
presented very briefly with each stimuli (Glendinning et al., 2002). Additionally, chemotherapy 
treatment significantly impairs olfactory function (Steinbach et al., 2008). These factors should 
control for olfaction which might otherwise conflict with taste cues.  
 A BAT was used in this study instead of a two-bottle preference test for several reasons. 
Two-bottle preference tests can induce post-ingestive effects which could confound results 
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(Spector, 2003). We attempted to control for post-ingestive effects by providing mice with water 
an hour after each session to limit gastric malaise induced by overconsumption of salt. BAT 
studies also allow for the presentation of multiple NaCl concentrations at one time, whereas two-
bottle preference tests limit each test to two solutions.  
Rodents vs. Humans 
 The difference in salt taste receptor cells in rodents and humans is not well studied. This 
is likely due to the general lack of knowledge about the cell types responsible for salt taste. In 
terms of umami taste, humans are 70% analogous to rodents for the T1R gene, responsible for 
umami taste detection (Hoon et al., 1999). For salt, amiloride in humans does not appear to alter 
the saltiness of NaCl, but it does reduce the “sour” taste associated with it. This indicates that 
there are species differences in the salt taste receptors (Breslin & Spector, 2008). Further 
research comparing rodent and human salt receptors should elucidate these differences, which 
will provide further insight into mammalian salt taste.  
CYP as a CTA Inducer 
 While our first study in Chapter II used lithium chloride to induce a CTA in mice, CYP is 
also an agent used to induce CTA in mice (Lin et al., 2014). We controlled for this potential 
confounding factor by giving the mice 24 hours of water before and after all CYP injections so 
that the CYP did not induce an aversion to NaCl. Additionally, the testing period (where NaCl 
was presented daily without CYP injection afterwards) would act as an extinction period, which 
would limit the effects of the potential CTA to NaCl induced by CYP. If a CTA to NaCl was 
induced by CYP, we would have expected to see lower lick rates for NaCl in CYP mice, which is 
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the opposite of what we observed. Therefore, CYP-induced CTA did not seem to confound our 
experiment.  
Implications for Chemotherapy Patients 
 The reduced salt sensitivity we observed in mice matches what is reported by 
chemotherapy patients. Additionally, the existence of a secondary salt taste cell type which is 
protected from CYP has important implications. If molecular studies can pinpoint the specific 
cell type involved and uncover the mechanism involved in CYP resistance, this same mechanism 
could potentially be utilized to protect other cell types from the toxic effects of CYP.  
Future Directions 
 A key to further uncovering the effects of CYP on salt taste is repeating the experiment 
with more mice under the same previous conditions. A higher number of subjects will improve 
our confidence about conclusions from these studies. Similar tests could also be performed 
involving NaCl solutions mixed with amiloride, which would eliminate effects of the amiloride-
sensitive pathway and focus wholly on the yet to be agreed upon amiloride-insensitive pathway. 
Additionally, discrimination work from Dr. Eugene Delay’s lab involving salt taste with CYP 
treated mice would be useful in supporting preference data from this study. Molecular studies 
would also be useful to uncover the other cell types that are involved in salt taste.  
Conclusion 
 Mice show a biphasic disturbance in NaCl taste following cyclophosphamide treatment. 
Phase 1 of this disturbance occurs around day 8, while phase 2 occurs around day 18. Mice 
conditioned to avoid NaCl maintain an aversion to low concentrations of NaCl following CYP 
treatment, pointing to a category of NaCl receptors which are protected from the effects of CYP. 
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Multiple CYP injections have the same effect as a single CYP injection as long as the overall 
dose is the same, indicating that this is not a useful method to disturb multiple salt receptor cell 
types. Our results support the hypothesis that multiple taste receptor populations are involved in 
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